- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 704259, 9 pages
Intracerebroventricular Administration of Nerve Growth Factor Induces Gliogenesis in Sensory Ganglia, Dorsal Root, and within the Dorsal Root Entry Zone
1Department of Molecular Neurology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), University Hospital Erlangen, Schwabachanlage 6, 91054 Erlangen, Germany
2Department of Neurosciences, University of California, La Jolla, San Diego, CA 92093-9157, USA
3Neurology Service, Veterans Affairs Medical Center, San Diego, CA 92161, USA
Received 25 August 2013; Revised 5 February 2014; Accepted 5 February 2014; Published 16 March 2014
Academic Editor: Gjumrakch Aliev
Copyright © 2014 Johannes C. M. Schlachetzki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. Levi-Montalcini, “The nerve growth factor 35 years later,” Science, vol. 237, no. 4819, pp. 1154–1162, 1987.
- A. Lambiase, L. Aloe, M. Centofanti, et al., “Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 32, pp. 13469–13474, 2009.
- M. H. Tuszynski, L. Thal, M. Pay et al., “A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease,” Nature Medicine, vol. 11, no. 5, pp. 551–555, 2005.
- V. M. K. Verge, R. J. Riopelle, and P. M. Richardson, “Nerve growth factor receptors on normal and injured sensory neurons,” Journal of Neuroscience, vol. 9, no. 3, pp. 914–922, 1989.
- J. S. Jacobs and M. W. Miller, “Expression of nerve growth factor, p75, and the high affinity neurotrophin receptors in the adult rat trigeminal system: evidence for multiple trophic support systems,” Journal of Neurocytology, vol. 28, no. 7, pp. 571–595, 1999.
- D. E. Wright and W. D. Snider, “Neurotrophin receptor mRNA expression defines distinct populations of neurons in rat dorsal root ganglia,” Journal of Comparative Neurology, vol. 351, no. 3, pp. 329–338, 1995.
- E. Pannese and P. Procacci, “Ultrastructural localization of NGF receptors in satellite cells of the rat spinal ganglia,” Journal of Neurocytology, vol. 31, no. 8-9, pp. 755–763, 2002.
- K. R. Jessen, L. Morgan, H. J. S. Stewart, and R. Mirsky, “Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP: development and regulation by neuron-Schwann cell interactions,” Development, vol. 109, no. 1, pp. 91–103, 1990.
- N. Offenhauser, R. Bohm-Matthaei, P. Tsoulfas, L. Parada, and M. Meyer, “Developmental regulation of full-length trkC in the rat sciatic nerve,” European Journal of Neuroscience, vol. 7, no. 5, pp. 917–925, 1995.
- D. E. Syroid, P. J. Maycox, M. Soilu-Hänninen et al., “Induction of postnatal schwann cell death by the low-affinity neurotrophin receptor in vitro and after axotomy,” Journal of Neuroscience, vol. 20, no. 15, pp. 5741–5747, 2000.
- J. R. Chan, T. A. Watkins, J. M. Cosgaya et al., “NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes,” Neuron, vol. 43, no. 2, pp. 183–191, 2004.
- C. A. Bentley and K. Lee, “p75 Is important for axon growth and Schwann cell migration during development,” Journal of Neuroscience, vol. 20, no. 20, pp. 7706–7715, 2000.
- T. Yamashita, K. L. Tucker, and Y. A. Barde, “Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth,” Neuron, vol. 24, no. 3, pp. 585–593, 1999.
- A. B. Cragnolini and W. J. Friedman, “The function of p75NTR in glia,” Trends in Neurosciences, vol. 31, no. 2, pp. 99–104, 2008.
- D. L. Stemple and D. J. Anderson, “Isolation of a stem cell for neurons and glia from the mammalian neural crest,” Cell, vol. 71, no. 6, pp. 973–985, 1992.
- J. F. Crane and P. A. Trainor, “Neural crest stem and progenitor cells,” Annual Review of Cell and Developmental Biology, vol. 22, pp. 267–286, 2006.
- F. Hefti and P. A. Lapchak, “Pharmacology of nerve growth factor in the brain,” Advances in Pharmacology, vol. 24, pp. 239–273, 1993.
- R. J. Mandel, F. H. Gage, D. G. Clevenger, S. K. Spratt, R. O. Snyder, and S. E. Leff, “Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration,” Experimental Neurology, vol. 155, no. 1, pp. 59–64, 1999.
- D. P. Pizzo and L. J. Thal, “Intraparenchymal nerve growth factor improves behavioral deficits while minimizing the adverse effects of intracerebroventricular delivery,” Neuroscience, vol. 124, no. 4, pp. 743–755, 2004.
- J. Winkler and L. J. Thal, “Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA,” Experimental Neurology, vol. 136, no. 2, pp. 234–250, 1995.
- K. S. Chen and F. H. Gage, “Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration,” Journal of Neuroscience, vol. 15, no. 4, pp. 2819–2825, 1995.
- C. H. Phelps, F. H. Gage, J. H. Growdon et al., “Potential use of nerve growth factor to treat Alzheimer's disease,” Neurobiology of Aging, vol. 10, no. 2, pp. 205–207, 1989.
- S. A. Lyness, C. Zarow, and H. C. Chui, “Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis,” Neurobiology of Aging, vol. 24, no. 1, pp. 1–23, 2003.
- E. K. Perry, B. E. Tomlinson, and G. Blessed, “Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia,” The British Medical Journal, vol. 2, no. 6150, pp. 1457–1459, 1978.
- P. J. Whitehouse, D. L. Price, and R. G. Struble, “Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain,” Science, vol. 215, no. 4537, pp. 1237–1239, 1982.
- R. Loy, G. Taglialatela, L. Angelucci, D. Heyer, and R. Perez-Polo, “Regional CNS uptake of blood-borne nerve growth factor,” Journal of Neuroscience Research, vol. 39, no. 3, pp. 339–346, 1994.
- L. R. Williams, “Exogenous nerve growth factor stimulates choline acetyltransferase activity in aging Fischer 344 male rats,” Neurobiology of Aging, vol. 12, no. 1, pp. 39–46, 1991.
- L. R. Williams, H. L. Vahlsing, and T. Lindamood, “A small-gauge cannula device for continuous infusion of exogenous agents into the brain,” Experimental Neurology, vol. 95, no. 3, pp. 743–754, 1987.
- L. G. Isaacson, B. N. Saffran, and K. A. Crutcher, “Nerve growth factor-induced sprouting of mature, uninjured sympathetic axons,” Journal of Comparative Neurology, vol. 326, no. 3, pp. 327–336, 1992.
- L. G. Isaacson, D. Ondris, and K. A. Crutcher, “Plasticity of mature sensory cerebrovascular axons following intracranial infusion of nerve growth factor,” Journal of Comparative Neurology, vol. 361, no. 3, pp. 451–460, 1995.
- J. Winkler, G. A. Ramirez, H. G. Kuhn et al., “Reversible schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor,” Annals of Neurology, vol. 41, no. 1, pp. 82–93, 1997.
- P. A. Day-Lollini, G. R. Stewart, M. J. Taylor, R. M. Johnson, and G. J. Chellman, “Hyperplastic changes within the leptomeninges of the rat and monkey in response to chronic intracerebroventricular infusion of nerve growth factor,” Experimental Neurology, vol. 145, no. 1, pp. 24–37, 1997.
- D. P. Pizzo, J. Winkler, I. Sidiqi, J. J. Waite, and L. J. Thal, “Modulation of sensory inputs and ectopic presence of Schwann cells depend upon the route and duration of nerve growth factor administration,” Experimental Neurology, vol. 178, no. 1, pp. 91–103, 2002.
- P. Dyck and P. K. Thomas, Peripheral Neuropathy, WB Saunders, London, UK, 4th edition, 2005.
- G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, Calif, USA, 1998.
- H. J. G. Gundersen, T. F. Bendtsen, L. Korbo et al., “Some new, simple and efficient stereological methods and their use in pathological research and diagnosis,” APMIS, vol. 96, no. 5, pp. 379–394, 1988.
- L. R. Williams, “Hypophagia is induced by intracerebroventricular administration of nerve growth factor,” Experimental Neurology, vol. 113, no. 1, pp. 31–37, 1991.
- P. A. Lapchak and D. M. Araujo, “NGF suppression of weight gain in adult female rats correlates with decreased hypothalamic cholecystokinin levels,” Brain Research, vol. 655, no. 1-2, pp. 12–16, 1994.
- J. Winkler, G. A. Ramirez, L. J. Thal, and J. J. Waite, “Nerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviors,” Journal of Neuroscience, vol. 20, no. 2, pp. 834–844, 2000.
- K. Elson, R. M. Ribeiro, A. S. Perelson, A. Simmons, and P. Speck, “The life span of ganglionic glia in murine sensory ganglia estimated by uptake of bromodeoxyuridine,” Experimental Neurology, vol. 186, no. 1, pp. 99–103, 2004.
- J. P. Fraher, “The CNS-PNS transitional zone of the rat. Morphometric studies at cranial and spinal levels,” Progress in Neurobiology, vol. 38, no. 3, pp. 261–316, 1992.
- R. P. Singh, Y. Cheng, P. Nelson, and F. C. Zhou, “Retentive multipotency of adult dorsal root ganglia stem cells,” Cell Transplantation, vol. 18, no. 1, pp. 55–68, 2009.
- H. Y. Li, E. H. Say, and X. F. Zhou, “Isolation and characterization of neural crest progenitors from adult dorsal root ganglia,” Stem Cells, vol. 25, no. 8, pp. 2053–2065, 2007.
- M. P. Namaka, M. Sawchuk, S. C. MacDonald, L. M. Jordan, and S. Hochman, “Neurogenesis in postnatal mouse dorsal root ganglia,” Experimental Neurology, vol. 172, no. 1, pp. 60–69, 2001.
- G. M. Kruger, J. T. Mosher, S. Bixby, N. Joseph, T. Iwashita, and S. J. Morrison, “Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness,” Neuron, vol. 35, no. 4, pp. 657–669, 2002.
- M. Liu, Y. Kuan, J. Wang, R. Hen, and M. D. Gershon, “5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice,” Journal of Neuroscience, vol. 29, no. 31, pp. 9683–9699, 2009.
- E. Dupin, C. Real, C. Glavieux-Pardanaud, P. Vaigot, and N. M. le Douarin, “Reversal of developmental restrictions in neural crest lineages: transition from Schwann cells to glial-melanocytic precursors in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 9, pp. 5229–5233, 2003.
- G. S. Marol, M. Vermeren, O. Voiculescu et al., “Neural crest boundary cap cells constitute a source of neuronal and glial cells of the PNS,” Nature Neuroscience, vol. 7, no. 9, pp. 930–938, 2004.
- A. Lagares, H. Li, X. Zhou, and C. Avendaño, “Primary sensory neuron addition in the adult rat trigeminal ganglion: evidence for neural crest glio-neuronal precursor maturation,” Journal of Neuroscience, vol. 27, no. 30, pp. 7939–7953, 2007.
- W. P. Gai, X. F. Zhou, and R. A. Rush, “Analysis of low affinity neurotrophin receptor (p75) expression in glia of the CNS-PNS transition zone following dorsal root transection,” Neuropathology and Applied Neurobiology, vol. 22, no. 5, pp. 434–439, 1996.
- A. D. O. Levi, R. P. Bunge, J. A. Lofgren et al., “The influence of heregulins on human Schwann cell proliferation,” Journal of Neuroscience, vol. 15, no. 2, pp. 1329–1340, 1995.
- T. K. Morrissey, A. D. O. Levi, A. Nuijens, M. X. Sliwkowski, and R. P. Bunge, “Axon-induced mitogenesis of human Schwann cells involves heregulin and p185(erbB2),” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 5, pp. 1431–1435, 1995.
- D. Wolpowitz, T. B. A. Mason, P. Dietrich, M. Mendelsohn, D. A. Talmage, and L. W. Role, “Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses,” Neuron, vol. 25, no. 1, pp. 79–91, 2000.
- J. A. Gomez-Sanchez, M. L. de Armentia, R. Lujan, N. Kessaris, W. D. Richardson, and H. Cabedo, “Sustained axon-glial signaling induces Schwann cell hyperproliferation, Remak bundle myelination, and tumorigenesis,” Journal of Neuroscience, vol. 29, no. 36, pp. 11304–11315, 2009.